We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I.
- Authors
Shah, P L; Scott, S F; Fuchs, H J; Geddes, D M; Hodson, M E
- Abstract
A phase II multicentre double blind placebo controlled study in 1993 showed that short term treatment (10 days) with recombinant human DNase I (rhDNase) was safe and improved pulmonary function in patients with cystic fibrosis with stable stage lung disease. A six month open label treatment study was conducted in some of the patients who participated in the short term study to assess the medium term effects of rhDNase.
- Publication
Thorax, 1995, Vol 50, Issue 4, p333
- ISSN
0040-6376
- Publication type
Journal Article
- DOI
10.1136/thx.50.4.333